Pharmacovigilance
Critique and Ways Forward
Editors:
Table of contents (18 chapters)
-
Front Matter
Pages i-xxxi
-
Chapter
Pages 1-8
Teaching Pharmacovigilance in University
-
Chapter
Pages 9-19
-
Chapter
Pages 21-30
What Is the Future of Pharmacovigilance and How Can We Make It as Good as Possible?
-
Chapter
Pages 31-33
Some Other Ideas About the Future of Pharmacovigilance
-
Chapter
Pages 35-48
Best Safety Practices Now and in the Future
-
Chapter
Pages 49-53
Is There a Benefit from the Medical Literature Monitoring Service of the EMA?
-
Chapter
Pages 55-66
The Unified Drug Safety-Clinical Database
-
Chapter
Pages 67-79
Behind the Scenes: ‘Silent Factors’ Influencing Pharmacovigilance Practice and Decisions
-
Chapter
Pages 81-97
Shaking Up Culture and Communication in PV [V6]
-
Chapter
Pages 99-114
Pharmacovigilance Indicators: Desiderata for the Future of Medicine Safety
-
Chapter
Pages 115-120
Thoughts on Pharmacovigilance in the Future: There Are More Weber-Effects
-
Chapter
Pages 121-130
Effective Treatment Matters: Revitalizing Pharmacovigilance
-
Chapter
Pages 131-144
Broadening the Scope of Pharmacovigilance
-
Chapter
Pages 145-159
Herbal and Traditional Medicines, Now and Future
-
Chapter
Pages 161-172
-
Chapter
Pages 173-179
Impact of Referral Procedures on the Interaction of RMP and PSUR
-
Chapter
Pages 181-193
Other Sources of Information for Monitoring Drug Safety: Now and in the Future
-
Chapter
Pages 195-205
Continue reading...
To view the rest of this content please follow the download PDF link above.
